Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML)

Uy, G.L., Rettig, M.P., Vey, N., Godwin, J., Foster, M.C., Rizzieri, D.A., Arellano, M.L., Topp, M.S., Huls, G., Jongen-Lavrencic, M., Martinelli, G., Paolini, S., Ciceri, F., Carrabba, M.G., Sweet, K.L., Ravandi, F., Church, S.E., Vadakekolathu, J., Rutella, S. ORCID: 0000-0003-1970-7375, Sun, J., Yang, K., Baughman, J., Curtis, T., Timmeny, E., Cali, K., Tran, K., Muth, J., La Motte-Mohs, R., Poirot, C., Pallis, A., Cesano, A., Bonvini, E., Wiggington, J., Lowenberg, B., Davidson-Moncada, J.K. and DiPersio, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971

Full text not available from this repository.
Item Type: Journal article
Publication Title: Blood
Creators: Uy, G.L., Rettig, M.P., Vey, N., Godwin, J., Foster, M.C., Rizzieri, D.A., Arellano, M.L., Topp, M.S., Huls, G., Jongen-Lavrencic, M., Martinelli, G., Paolini, S., Ciceri, F., Carrabba, M.G., Sweet, K.L., Ravandi, F., Church, S.E., Vadakekolathu, J., Rutella, S., Sun, J., Yang, K., Baughman, J., Curtis, T., Timmeny, E., Cali, K., Tran, K., Muth, J., La Motte-Mohs, R., Poirot, C., Pallis, A., Cesano, A., Bonvini, E., Wiggington, J., Lowenberg, B., Davidson-Moncada, J.K. and DiPersio, J.F.
Publisher: American Society of Hematology
Date: 29 November 2018
Volume: 132
Number: S1
ISSN: 0006-4971
Identifiers:
NumberType
10.1182/blood-2018-99-117085DOI
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 19 Dec 2018 11:02
Last Modified: 03 Sep 2019 15:07
Related URLs:
URI: http://irep.ntu.ac.uk/id/eprint/35386

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year